Atrium Research Estimates Bimergen Energy Q2 Earnings

Bimergen Energy Corporation (NYSEAMERICAN:BESS) – Equities researchers at Atrium Research issued their Q2 2026 earnings per share estimates for shares of Bimergen Energy in a research report issued to clients and investors on Monday, June 8th. Atrium Research analyst N. Cortellucci anticipates that the company will post earnings of ($0.39) per share for the quarter. Atrium Research has a “Strong-Buy” rating on the stock. The consensus estimate for Bimergen Energy’s current full-year earnings is $0.11 per share. Atrium Research also issued estimates for Bimergen Energy’s Q3 2026 earnings at $0.09 EPS, Q4 2026 earnings at $0.61 EPS, FY2026 earnings at ($0.41) EPS, Q1 2027 earnings at $0.29 EPS, Q2 2027 earnings at $0.21 EPS, Q3 2027 earnings at $0.19 EPS, Q4 2027 earnings at $0.50 EPS, FY2027 earnings at $1.19 EPS and FY2028 earnings at $4.40 EPS.

A number of other research firms have also commented on BESS. ThinkEquity raised Bimergen Energy to a “strong-buy” rating in a research report on Monday, May 4th. Zacks Research upgraded shares of Bimergen Energy to a “hold” rating in a research note on Monday, May 4th. Two analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Bimergen Energy Stock Performance

Shares of NYSEAMERICAN:BESS opened at $4.50 on Wednesday. Bimergen Energy has a 12-month low of $2.00 and a 12-month high of $17.12. The company has a market cap of $31.95 million, a P/E ratio of -2.63 and a beta of 2.49.

Bimergen Energy Company Profile

Spine Injury Solutions, Inc provides a suite of revolutionary electrical power generation technologies. The company intends to offer Evirontek Integrated Platform to the cryptocurrency mining industry to reduce the exorbitant high cost of electricity. It also provides spine injury diagnostic services; and owns, develops, and leases the Quad Video Halo video recording system used to record medical procedures. The company is based in Costa Mesa, California.